INVESCO EXCH TRADED FD TR II - GLOBAL EX US HGH (PGHY)

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class
Equity / GLOBAL EX US HGH
Total 13F shares
5,122,603
Share change
-615,264
Total reported value
$98,736,151
Price per share
$19.27
Number of holders
61
Value change
-$12,132,827
Number of buys
24
Number of sells
37

Institutional Holders of INVESCO EXCH TRADED FD TR II - GLOBAL EX US HGH (PGHY) as of Q2 2022

As of 30 Jun 2022, INVESCO EXCH TRADED FD TR II - GLOBAL EX US HGH (PGHY) was held by 61 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,122,603 shares. The largest 10 holders included Whitcomb & Hess, Inc., ADVISOR GROUP HOLDINGS, INC., Essex LLC, CERITY PARTNERS LLC, CABOT WEALTH MANAGEMENT INC, Janney Montgomery Scott LLC, AE Wealth Management LLC, Royal Fund Management, LLC, MORGAN STANLEY, and Hightower 6M Holding, LLC. This page lists 61 institutional shareholders reporting positions in this security for the Q2 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.